News Technology

Global Artificial Pancreas Devices Systems Market Report 2019, Industry Analysis by Innovations, Key Companies, Tremendous Growth, Technologies, Regional Analysis, Application and Specification till 2024

ORBIS RESEARCH announces the addition of a global detailed report on the Artificial Pancreas Devices Systems Market to gain better insights into the global market. The report also provides 360-degree informational data about the market, including many aspects of the market such as drivers, restraints, challenges, key regional and worldwide growth opportunities.

Access the PDF sample of the report @ https://www.orbisresearch.com/contacts/request-sample/2829538

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a “closed-loop” system, an “automated insulin delivery” system, or an “autonomous system for glycemic control.”

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.

The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.

Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.

North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.

According to this study, over the next five years the Artificial Pancreas Devices Systems market will register a 13.8% CAGR in terms of revenue, the global market size will reach US$ 120 million by 2024, from US$ 56 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artificial Pancreas Devices Systems business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Pancreas Devices Systems market by product type, application, key manufacturers and key regions and countries.

This study considers the Artificial Pancreas Devices Systems value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Threshold Suspended Device Systems

Hybrid Closed-loop APDS

Other Systems

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Hospitals

Clinics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Medtronic

Bigfoot Biomedical

Beta Bionics

Admetsys

Insulet

Tandem Diabetes Care

Defymed

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Artificial Pancreas Devices Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Artificial Pancreas Devices Systems market by identifying its various subsegments.

Focuses on the key global Artificial Pancreas Devices Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Artificial Pancreas Devices Systems with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Artificial Pancreas Devices Systems submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Browse the full report @ https://www.orbisresearch.com/reports/index/global-artificial-pancreas-devices-systems-market-growth-2019-2024

Table of Contents

2019-2024 Global Artificial Pancreas Devices Systems Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Artificial Pancreas Devices Systems Consumption 2014-2024

2.1.2 Artificial Pancreas Devices Systems Consumption CAGR by Region

2.2 Artificial Pancreas Devices Systems Segment by Type

2.2.1 Threshold Suspended Device Systems

2.2.2 Hybrid Closed-loop APDS

2.2.3 Other Systems

2.3 Artificial Pancreas Devices Systems Consumption by Type

2.3.1 Global Artificial Pancreas Devices Systems Consumption Market Share by Type (2014-2019)

2.3.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Type (2014-2019)

2.3.3 Global Artificial Pancreas Devices Systems Sale Price by Type (2014-2019)

2.4 Artificial Pancreas Devices Systems Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.5 Artificial Pancreas Devices Systems Consumption by Application

2.5.1 Global Artificial Pancreas Devices Systems Consumption Market Share by Application (2014-2019)

2.5.2 Global Artificial Pancreas Devices Systems Value and Market Share by Application (2014-2019)

2.5.3 Global Artificial Pancreas Devices Systems Sale Price by Application (2014-2019)

3 Global Artificial Pancreas Devices Systems by Players

3.1 Global Artificial Pancreas Devices Systems Sales Market Share by Players

3.1.1 Global Artificial Pancreas Devices Systems Sales by Players (2017-2019)

3.1.2 Global Artificial Pancreas Devices Systems Sales Market Share by Players (2017-2019)

3.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Players

3.2.1 Global Artificial Pancreas Devices Systems Revenue by Players (2017-2019)

3.2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Players (2017-2019)

3.3 Global Artificial Pancreas Devices Systems Sale Price by Players

3.4 Global Artificial Pancreas Devices Systems Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Artificial Pancreas Devices Systems Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Artificial Pancreas Devices Systems Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Artificial Pancreas Devices Systems by Regions

4.1 Artificial Pancreas Devices Systems by Regions

4.1.1 Global Artificial Pancreas Devices Systems Consumption by Regions

4.1.2 Global Artificial Pancreas Devices Systems Value by Regions

4.2 Americas Artificial Pancreas Devices Systems Consumption Growth

4.3 APAC Artificial Pancreas Devices Systems Consumption Growth

4.4 Europe Artificial Pancreas Devices Systems Consumption Growth

4.5 Middle East & Africa Artificial Pancreas Devices Systems Consumption Growth

5 Americas

5.1 Americas Artificial Pancreas Devices Systems Consumption by Countries

5.1.1 Americas Artificial Pancreas Devices Systems Consumption by Countries (2014-2019)

5.1.2 Americas Artificial Pancreas Devices Systems Value by Countries (2014-2019)

5.2 Americas Artificial Pancreas Devices Systems Consumption by Type

5.3 Americas Artificial Pancreas Devices Systems Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Artificial Pancreas Devices Systems Consumption by Countries

6.1.1 APAC Artificial Pancreas Devices Systems Consumption by Countries (2014-2019)

6.1.2 APAC Artificial Pancreas Devices Systems Value by Countries (2014-2019)

6.2 APAC Artificial Pancreas Devices Systems Consumption by Type

6.3 APAC Artificial Pancreas Devices Systems Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Artificial Pancreas Devices Systems by Countries

7.1.1 Europe Artificial Pancreas Devices Systems Consumption by Countries (2014-2019)

7.1.2 Europe Artificial Pancreas Devices Systems Value by Countries (2014-2019)

7.2 Europe Artificial Pancreas Devices Systems Consumption by Type

7.3 Europe Artificial Pancreas Devices Systems Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Artificial Pancreas Devices Systems by Countries

8.1.1 Middle East & Africa Artificial Pancreas Devices Systems Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Artificial Pancreas Devices Systems Value by Countries (2014-2019)

8.2 Middle East & Africa Artificial Pancreas Devices Systems Consumption by Type

8.3 Middle East & Africa Artificial Pancreas Devices Systems Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Artificial Pancreas Devices Systems Distributors

10.3 Artificial Pancreas Devices Systems Customer

11 Global Artificial Pancreas Devices Systems Market Forecast

11.1 Global Artificial Pancreas Devices Systems Consumption Forecast (2019-2024)

11.2 Global Artificial Pancreas Devices Systems Forecast by Regions

11.2.1 Global Artificial Pancreas Devices Systems Forecast by Regions (2019-2024)

11.2.2 Global Artificial Pancreas Devices Systems Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Artificial Pancreas Devices Systems Forecast by Type

11.8 Global Artificial Pancreas Devices Systems Forecast by Application

12 Key Players Analysis

12.1 Medtronic

12.1.1 Company Details

12.1.2 Artificial Pancreas Devices Systems Product Offered

12.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Medtronic News

12.2 Bigfoot Biomedical

12.2.1 Company Details

12.2.2 Artificial Pancreas Devices Systems Product Offered

12.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Bigfoot Biomedical News

12.3 Beta Bionics

12.3.1 Company Details

12.3.2 Artificial Pancreas Devices Systems Product Offered

12.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Beta Bionics News

12.4 Admetsys

12.4.1 Company Details

12.4.2 Artificial Pancreas Devices Systems Product Offered

12.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Admetsys News

12.5 Insulet

12.5.1 Company Details

12.5.2 Artificial Pancreas Devices Systems Product Offered

12.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Insulet News

12.6 Tandem Diabetes Care

12.6.1 Company Details

12.6.2 Artificial Pancreas Devices Systems Product Offered

12.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Tandem Diabetes Care News

12.7 Defymed

12.7.1 Company Details

12.7.2 Artificial Pancreas Devices Systems Product Offered

12.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 Defymed News

13 Research Findings and Conclusion

Direct purchase the report @ https://www.orbisresearch.com/contact/purchase-single-user/2829538

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (972)-362-8199; +91 895 659 5155

/* ]]> */